Cara Therapeutics (CARA) R&D/CAPEX US GAAP (year values)

2020 2021 2022 2023 2023   LTM ? CAGR 5 years ?
R&D/CAPEX, % 30 903% 212 054% 213 672% 4 569%   1 969%  
Changes by years, y/y, % -601 430pp +181 151pp +1 618pp -213 672pp     -46.4%

Cara Therapeutics. R&D/CAPEX, %

Cara Therapeutics. R&D/CAPEX, changes, pp

Cara Therapeutics (CARA) R&D/CAPEX US GAAP (quarter values)

2023Q3 2023Q4 2023Q4 2024Q1 2024Q2   LTM ?
R&D/CAPEX, % 7 880% 1 383% 2 626% 4 432%   1 969%
Changes by years, y/y, %    
Changes by quarters, q/q, % -7 880pp +1 243pp +1 807pp    

Cara Therapeutics. R&D/CAPEX, %

Cara Therapeutics. R&D/CAPEX, changes, pp

Cara Therapeutics. R&D/CAPEX, changes, pp